While the uncertainty rocks the US centers for the control of the disease and the national health institutes in bird flu, the US Ministry of Agriculture is still wearing the torch.
In the past few weeks, the concerns about bird flu have grown, since the US government has continued to conclude clinical research, epidemiology and pandemic readiness. Fortunately, the Ministry of Agriculture will mainly concentrate on bird flu in commercial poultry operation and milk flocks, and will continue to monitor the epidemic. In the long term, the restoration of financing for the CDC and NIH infection and immunity programs is of crucial importance for North American organic security. Although the Ministry of Agriculture is not ideal, it may be able to keep your finger in the dike until the financing is restored.
In a communication emitted this week, the USDA announced a financing competition with which research to combat the highly pathogenic tribes of the Avain Influenza, which is currently supposed to strengthen on poultry farms in the USA. The agency will finance projects of prevention, therapeutics and vaccines based on urgency. With an investment of 100 million US dollars, the government authority will prioritize projects on which concentrate on
- Development of new therapeutic agents and improved diagnostics for the treatment of HPAI in poultry.
- Research on the further understanding of the risk routes of the Vogel Influenza for producers and for information improved strategies for organic security and reaction.
- Development of new vaccines for the protection of poultry from HPAI and at the same time promotes organic security.
The USDA set a deadline of May 19, 2025. You can find more information about this financing option under grants.